Results CHD-COPD co-morbidity prevalence showed no statistically significant increase from 2020 to 2024; although the estimated linear trend was positive, it did not reach statistical significance (OR per 1-year increase = 1.04; 95% CI: 0.997–1.08; p = 0.072).
← all excerpts
Coronary heart disease and chronic obstructive pulmonary disease prevalence and temporal trends among United States adults: a national population-based study.
1
0.0720
0.0720